• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在临床试验中,是否可以避免对溃疡性结肠炎进行内镜评估?

Can endoscopy be avoided in the assessment of ulcerative colitis in clinical trials?

机构信息

School of Clinical Sciences, University of Bristol, Bristol, UK.

出版信息

Inflamm Bowel Dis. 2012 Nov;18(11):2056-62. doi: 10.1002/ibd.22879. Epub 2012 Jan 23.

DOI:10.1002/ibd.22879
PMID:22271464
Abstract

BACKGROUND

There is no gold standard index in the measurement of ulcerative colitis (UC) disease activity in clinical trials. Mucosal healing has been described as an important clinical endpoint requiring endoscopic assessment, which is unpleasant for the patient and may hamper recruitment to trials. The aim of this study was to determine whether endoscopy is necessary in the assessment of UC disease activity and whether a noninvasive disease activity index (partial Mayo score) could be used to predict the Mayo score.

METHODS

In all, 149 subjects with moderate to severe UC enrolled in a clinical trial were assessed using total and partial Mayo scores. Histologic assessment of biopsies was performed. A regression model was constructed to predict total Mayo score from the partial Mayo score and histology score from the Mayo score. A Bland-Altman test of agreement was performed.

RESULTS

The partial Mayo score correlated closely with the total Mayo score at week 4 (rho = 0.97) and week 8 (rho = 0.98). The model to predict total from partial Mayo score showed excellent correlation (rho = 0.97) and good agreement with the total Mayo score at week 4 and the week 8 validation set (rho = 0.97) and accurately classified disease severity (kappa = 0.82). The model to predict histology score from the Mayo score correlated only moderately with the actual histology score at week 4 (rho = 0.59) and week 8 (rho = 0.36).

CONCLUSIONS

The Mayo score can be accurately predicted from the partial Mayo score. A noninvasive index can replace the Mayo score in future clinical trials.

摘要

背景

在临床试验中,溃疡性结肠炎(UC)疾病活动度的测量尚无金标准指标。黏膜愈合已被描述为需要内镜评估的重要临床终点,这对患者来说是不愉快的,可能会阻碍试验的招募。本研究旨在确定内镜评估在 UC 疾病活动度评估中的必要性,以及非侵入性疾病活动指数(部分 Mayo 评分)是否可用于预测 Mayo 评分。

方法

共有 149 名中度至重度 UC 患者入组临床试验,使用总 Mayo 评分和部分 Mayo 评分进行评估。对活检进行组织学评估。构建了一个回归模型,以预测总 Mayo 评分来自部分 Mayo 评分,预测 Mayo 评分中的组织学评分来自部分 Mayo 评分。进行了 Bland-Altman 一致性检验。

结果

第 4 周(rho=0.97)和第 8 周(rho=0.98)时,部分 Mayo 评分与总 Mayo 评分密切相关。预测总 Mayo 评分来自部分 Mayo 评分的模型显示出极好的相关性(rho=0.97),并与第 4 周和第 8 周验证集的总 Mayo 评分有良好的一致性(rho=0.97),并准确地分类了疾病严重程度(kappa=0.82)。预测 Mayo 评分中组织学评分的模型仅与第 4 周(rho=0.59)和第 8 周(rho=0.36)的实际组织学评分中度相关。

结论

可以从部分 Mayo 评分准确预测 Mayo 评分。未来的临床试验中,可以用非侵入性指数替代 Mayo 评分。

相似文献

1
Can endoscopy be avoided in the assessment of ulcerative colitis in clinical trials?在临床试验中,是否可以避免对溃疡性结肠炎进行内镜评估?
Inflamm Bowel Dis. 2012 Nov;18(11):2056-62. doi: 10.1002/ibd.22879. Epub 2012 Jan 23.
2
Endoscopic scoring indices for evaluation of disease activity in ulcerative colitis.用于评估溃疡性结肠炎疾病活动度的内镜评分指数。
Cochrane Database Syst Rev. 2018 Jan 16;1(1):CD011450. doi: 10.1002/14651858.CD011450.pub2.
3
Correlation of endoscopic disease severity with pediatric ulcerative colitis activity index score in children and young adults with ulcerative colitis.儿童及青年溃疡性结肠炎患者内镜下疾病严重程度与小儿溃疡性结肠炎活动指数评分的相关性
World J Gastroenterol. 2017 May 14;23(18):3322-3329. doi: 10.3748/wjg.v23.i18.3322.
4
Clinical, endoscopic and histological correlation and measures of association in ulcerative colitis.溃疡性结肠炎的临床、内镜和组织学相关性及关联度量。
J Dig Dis. 2017 Nov;18(11):634-641. doi: 10.1111/1751-2980.12546.
5
Level of Fecal Calprotectin Correlates With Endoscopic and Histologic Inflammation and Identifies Patients With Mucosal Healing in Ulcerative Colitis.粪便钙卫蛋白水平与溃疡性结肠炎的内镜和组织学炎症相关,并可识别出黏膜愈合的患者。
Clin Gastroenterol Hepatol. 2015 Nov;13(11):1929-36.e1. doi: 10.1016/j.cgh.2015.05.038. Epub 2015 Jun 4.
6
A composite disease activity index for early drug development in ulcerative colitis: development and validation of the UC-100 score.用于溃疡性结肠炎早期药物开发的综合疾病活动指数:UC-100 评分的制定和验证。
Lancet Gastroenterol Hepatol. 2019 Jan;4(1):63-70. doi: 10.1016/S2468-1253(18)30306-6. Epub 2018 Oct 18.
7
Evaluation of the Risk of Relapse in Ulcerative Colitis According to the Degree of Mucosal Healing (Mayo 0 vs 1): A Longitudinal Cohort Study.根据黏膜愈合程度(梅奥0级与1级)评估溃疡性结肠炎复发风险:一项纵向队列研究
J Crohns Colitis. 2016 Jan;10(1):13-9. doi: 10.1093/ecco-jcc/jjv158. Epub 2015 Sep 7.
8
An optimized patient-reported ulcerative colitis disease activity measure derived from the Mayo score and the simple clinical colitis activity index.从 Mayo 评分和简单临床结肠炎活动指数优化而来的溃疡性结肠炎患者报告疾病活动度测量指标。
Inflamm Bowel Dis. 2014 Jun;20(6):1070-8. doi: 10.1097/MIB.0000000000000053.
9
Developing an instrument to assess the endoscopic severity of ulcerative colitis: the Ulcerative Colitis Endoscopic Index of Severity (UCEIS).开发一种评估溃疡性结肠炎内镜严重程度的工具:溃疡性结肠炎内镜严重程度指数(UCEIS)。
Gut. 2012 Apr;61(4):535-42. doi: 10.1136/gutjnl-2011-300486. Epub 2011 Oct 13.
10
Agreement Between Rectosigmoidoscopy and Colonoscopy Analyses of Disease Activity and Healing in Patients With Ulcerative Colitis.直肠乙状结肠镜检查与结肠镜检查分析溃疡性结肠炎患者的疾病活动度和愈合情况。
Gastroenterology. 2016 Feb;150(2):389-95.e3. doi: 10.1053/j.gastro.2015.10.016. Epub 2015 Oct 23.

引用本文的文献

1
Effect of a high dose atorvastatin as adjuvant therapy to mesalamine in attenuating inflammation and symptoms in patients with ulcerative colitis: a randomized controlled pilot study.高剂量阿托伐他汀作为美沙拉嗪辅助治疗对减轻溃疡性结肠炎患者炎症和症状的影响:一项随机对照试验性研究
Front Med (Lausanne). 2025 Jan 22;11:1490178. doi: 10.3389/fmed.2024.1490178. eCollection 2024.
2
Psychological Features in the Inflammatory Bowel Disease-Irritable Bowel Syndrome Overlap: Developing a Preliminary Understanding of Cognitive and Behavioral Factors.炎症性肠病-肠易激综合征重叠中的心理特征:对认知和行为因素形成初步理解
Crohns Colitis 360. 2021 Aug 26;3(3):otab061. doi: 10.1093/crocol/otab061. eCollection 2021 Jul.
3
Has the COVID-19 Pandemic Worsened Health-Related Quality of Life of Patients with Inflammatory Bowel Disease? A Longitudinal Disease Activity-Controlled Study.
新冠疫情是否恶化了炎症性肠病患者的健康相关生活质量?一项基于疾病活动控制的纵向研究。
Int J Environ Res Public Health. 2023 Jan 8;20(2):1103. doi: 10.3390/ijerph20021103.
4
Detailed Transcriptional Landscape of Peripheral Blood Points to Increased Neutrophil Activation in Treatment-Naïve Inflammatory Bowel Disease.外周血的详细转录图谱表明,初治炎症性肠病患者中性粒细胞激活增加。
J Crohns Colitis. 2022 Aug 4;16(7):1097-1109. doi: 10.1093/ecco-jcc/jjac003.
5
Ultra-high Magnification Endocytoscopy and Molecular Markers for Defining Endoscopic and Histologic Remission in Ulcerative Colitis-An Exploratory Study to Define Deep Remission.超高倍放大内镜下内吞体观察与分子标志物在溃疡性结肠炎内镜及组织学缓解中的应用——一项探索性研究以定义深度缓解
Inflamm Bowel Dis. 2021 Oct 20;27(11):1719-1730. doi: 10.1093/ibd/izab059.
6
Influence of the COVID-19 Outbreak on Disease Activity and Quality of Life in Inflammatory Bowel Disease Patients.新型冠状病毒肺炎疫情对炎症性肠病患者疾病活动及生活质量的影响
Front Psychiatry. 2021 Apr 22;12:664088. doi: 10.3389/fpsyt.2021.664088. eCollection 2021.
7
Recurrent myocarditis in a patient with active ulcerative colitis: a case report and review of the literature.活动期溃疡性结肠炎患者反复发生心肌炎:病例报告及文献复习。
BMJ Open Gastroenterol. 2021 Mar;8(1). doi: 10.1136/bmjgast-2020-000587.
8
The impact of clinical symptoms and endoscopic and histologic disease activity on health-related quality of life in patients with ulcerative colitis following treatment with multimatrix mesalazine.多基质美沙拉嗪治疗后溃疡性结肠炎患者的临床症状、内镜及组织学疾病活动度对健康相关生活质量的影响
Qual Life Res. 2021 Jul;30(7):1925-1938. doi: 10.1007/s11136-021-02787-4. Epub 2021 Mar 2.
9
Myosin Light Chain 9/12 Regulates the Pathogenesis of Inflammatory Bowel Disease.肌球蛋白轻链9/12调节炎症性肠病的发病机制。
Front Immunol. 2021 Jan 29;11:594297. doi: 10.3389/fimmu.2020.594297. eCollection 2020.
10
Current Endpoints of Clinical Trials in Ulcerative Colitis: Are They Valid?溃疡性结肠炎临床试验的当前终点:它们有效吗?
Curr Treat Options Gastroenterol. 2020 Jan 4;18(1):15-32. doi: 10.1007/s11938-019-00259-w. Print 2020 Mar.